These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8566349)

  • 21. Harman (1-methyl-beta-carboline) is a natural inhibitor of monoamine oxidase type A in rats.
    Rommelspacher H; May T; Salewski B
    Eur J Pharmacol; 1994 Jan; 252(1):51-9. PubMed ID: 8149995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoamine oxidase A inhibitory potency and flavin perturbation are influenced by different aspects of pirlindole inhibitor structure.
    Hynson RM; Wouters J; Ramsay RR
    Biochem Pharmacol; 2003 Jun; 65(11):1867-74. PubMed ID: 12781338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insight into the functional and structural properties of 3-arylcoumarin as an interesting scaffold in monoamine oxidase B inhibition.
    Matos MJ; Vilar S; García-Morales V; Tatonetti NP; Uriarte E; Santana L; Viña D
    ChemMedChem; 2014 Jul; 9(7):1488-500. PubMed ID: 24715707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of monoamine oxidase by benzoxathiolone analogues.
    Mostert S; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1200-4. PubMed ID: 26821818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoamine oxidases: to inhibit or not to inhibit.
    Ramsay RR; Gravestock MB
    Mini Rev Med Chem; 2003 Mar; 3(2):129-36. PubMed ID: 12570845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoamine oxidase (MAO) inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins.
    Delogu GL; Serra S; Quezada E; Uriarte E; Vilar S; Tatonetti NP; Viña D
    ChemMedChem; 2014 Aug; 9(8):1672-6. PubMed ID: 24782464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concentration dependence of the oxidation of tyramine by the two forms of rat liver mitochondrial monoamine oxidase.
    Fowler CJ; Tipton KF
    Biochem Pharmacol; 1981 Dec; 30(24):3329-32. PubMed ID: 7326042
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibitors alter the spectrum and redox properties of monoamine oxidase A.
    Ramsay RR; Hunter DJ
    Biochim Biophys Acta; 2002 Dec; 1601(2):178-84. PubMed ID: 12445480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation on the structure of the active site of monoamine oxidase-B by affinity labeling with the selective inhibitor lazabemide and by site-directed mutagenesis.
    Cesura AM; Gottowik J; Lahm HW; Lang G; Imhof R; Malherbe P; Röthlisberger U; Da Prada M
    Eur J Biochem; 1996 Mar; 236(3):996-1002. PubMed ID: 8665924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polystyrene microbridges used in sitting-drop crystallization release 1,4-diphenyl-2-butene, a novel inhibitor of human MAO B.
    Hubálek F; Binda C; Li M; Mattevi A; Edmondson DE
    Acta Crystallogr D Biol Crystallogr; 2003 Oct; 59(Pt 10):1874-6. PubMed ID: 14501143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of monoamine oxidase (MAO) enzymatic activity by high-performance liquid chromatography-diode array detection combined with an assay of oxidation with a peroxidase and its application to MAO inhibitors from foods and plants.
    Herraiz T; Flores A; Fernández L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():136-144. PubMed ID: 29268246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orientation of oxazolidinones in the active site of monoamine oxidase.
    Jones TZ; Fleming P; Eyermann CJ; Gravestock MB; Ramsay RR
    Biochem Pharmacol; 2005 Aug; 70(3):407-16. PubMed ID: 15950194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies.
    Sahoo A; Yabanoglu S; Sinha BN; Ucar G; Basu A; Jayaprakash V
    Bioorg Med Chem Lett; 2010 Jan; 20(1):132-6. PubMed ID: 19945874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.
    Karuppasamy M; Mahapatra M; Yabanoglu S; Ucar G; Sinha BN; Basu A; Mishra N; Sharon A; Kulandaivelu U; Jayaprakash V
    Bioorg Med Chem; 2010 Mar; 18(5):1875-81. PubMed ID: 20149663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the structural basis of the selective inhibition of monoamine oxidase A by dicarbonitrile aminoheterocycles: role of Asn181 and Ile335 validated by spectroscopic and computational studies.
    Juárez-Jiménez J; Mendes E; Galdeano C; Martins C; Silva DB; Marco-Contelles J; do Carmo Carreiras M; Luque FJ; Ramsay RR
    Biochim Biophys Acta; 2014 Feb; 1844(2):389-97. PubMed ID: 24247011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biosensor based on inhibition of monoamine oxidases A and B for detection of β-carbolines.
    Radulescu MC; Bucur MP; Bucur B; Radu GL
    Talanta; 2015 May; 137():94-9. PubMed ID: 25770611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines.
    Vintém AP; Price NT; Silverman RB; Ramsay RR
    Bioorg Med Chem; 2005 May; 13(10):3487-95. PubMed ID: 15848762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of monoamine oxidase by indole-5,6-dicarbonitrile derivatives.
    Chirkova ZV; Kabanova MV; Filimonov SI; Abramov IG; Petzer A; Petzer JP; Firgang SI; Suponitsky KY
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1206-11. PubMed ID: 25701250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of tetrahydro-beta-carbolines on monoamine oxidase and serotonin uptake in mouse brain.
    Buckholtz NS; Boggan WO
    Biochem Pharmacol; 1976 Oct; 25(20):2319-31. PubMed ID: 985563
    [No Abstract]   [Full Text] [Related]  

  • 40. On the binding of monoamine oxidase inhibitors to some sites distinct from the MAO active site, and effects thereby elicited.
    Holt A; Berry MD; Boulton AA
    Neurotoxicology; 2004 Jan; 25(1-2):251-66. PubMed ID: 14697900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.